Mr. Asadorian was appointed chief financial officer in August 2017.
Mr. Asadorian brings over 25 years of finance, strategy and corporate development experience to AcelRx. Prior to joining AcelRx, Mr. Asadorian served as the Chief Financial Officer of Amyris, Inc., a publicly traded commercial-stage biotechnology company, from 2015-2017. Prior to Amyris, he served as the Chief Financial Officer of Unilabs, a private equity-owned medical diagnostics company, from 2009-2014.
Mr. Asadorian started his career at PricewaterhouseCoopers (PwC) where he was a partner in its Transaction Services (M&A advisory) group. While at PwC, Mr. Asadorian advised Barr Pharmaceuticals, a publicly traded specialty pharmaceutical company, on its acquisition of PLIVA, a publicly traded pharmaceutical company, and, after its acquisition, Mr. Asadorian joined Barr as Senior Vice President and Chief Financial Officer of its PLIVA business from 2007-2009. In that role, Mr. Asadorian oversaw a global finance team and was responsible for Barr’s ex-US financial operations, until its acquisition by Teva Pharmaceuticals.
Mr. Asadorian holds a Bachelor of Science in Business Administration degree from Xavier University and a Master of Business Administration degree from the University of Manchester (UK).
What is Raffi Asadorian's net worth?
The estimated net worth of Raffi Asadorian is at least $106.31 thousand as of February 12th, 2026. Mr. Asadorian owns 91,256 shares of Talphera stock worth more than $106,313 as of September 23rd. This net worth evaluation does not reflect any other assets that Mr. Asadorian may own. Learn More about Raffi Asadorian's net worth.
How do I contact Raffi Asadorian?
Has Raffi Asadorian been buying or selling shares of Talphera?
Raffi Asadorian has not been actively trading shares of Talphera during the past quarter. Most recently, on Thursday, February 12th, Raffi Asadorian bought 45,000 shares of Talphera stock. The stock was acquired at an average cost of $0.81 per share, with a total value of $36,450.00. Following the completion of the transaction, the chief financial officer now directly owns 91,256 shares of the company's stock, valued at $73,917.36. Learn More on Raffi Asadorian's trading history.
Who are Talphera's active insiders?
Are insiders buying or selling shares of Talphera?
In the last year, Talphera insiders bought shares 5 times. They purchased a total of 433,674 shares worth more than $304,347.74. The most recent insider tranaction occured on March, 13th when CEO Vincent J Angotti bought 213,310 shares worth more than $125,852.90. Insiders at Talphera own 3.5% of the company.
Learn More about insider trades at Talphera. Information on this page was last updated on 3/13/2026.
